Sustain Results: Maintain your progress with continued support and lifestyle coaching
Sweetened with maple sugar, molasses, and monk fruit, with no artificial colors or flavors
Retatrutide, an investigational triple GIP, GLP-1, and glucagon receptor agonist, has produced substantial weight loss in phase 2 obesity trials and promising topline phase 3 results
Central GLP-1 receptor signalling accelerates plasma clearance of triacylglycerol and glucose by activating brown adipose tissue in mice
The preventive role of zinc and selenium against cancer is more likely due to its antioxidant activity
In 2024 alone, Canadian insurers paid nearly $77 million in claims for weight-management drugs, a figure that nearly doubled year over year [Source: endorhealth.com/article/generic-ozempic-coming-to-canada]